title	geo_accession	status	submission_date	last_update_date	type	channel_count	source_name_ch1	organism_ch1	characteristics_ch1	characteristics_ch1.1	characteristics_ch1.2	characteristics_ch1.3	characteristics_ch1.4	characteristics_ch1.5	characteristics_ch1.6	treatment_protocol_ch1	molecule_ch1	extract_protocol_ch1	label_ch1	label_protocol_ch1	taxid_ch1	hyb_protocol	scan_protocol	data_processing	platform_id	contact_name	contact_email	contact_department	contact_institute	contact_address	contact_city	contact_zip/postal_code	contact_country	supplementary_file	data_row_count	relation	age:ch1	fab:ch1	life status:ch1	overall survival (days):ch1	runx1-runx1t1_fusion:ch1	runx1_mutation:ch1	tissue:ch1
AML_patient_1	GSM923596	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 67	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 186	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923596/suppl/GSM923596_AHW_AML_aa_024025_44_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	67	1	dead	186	No	No	bone marrow mononuclear cells
AML_patient_2	GSM923597	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 45	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3537	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923597/suppl/GSM923597_AHW_AML_aa_024035_91_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	45	1	alive	3537	No	No	bone marrow mononuclear cells
AML_patient_3	GSM923598	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 51	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 123	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923598/suppl/GSM923598_AHW_AML_aa_024328_40_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	51	1	dead	123	No	No	bone marrow mononuclear cells
AML_patient_4	GSM923599	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 42	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3395	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923599/suppl/GSM923599_AHW_AML_aa_024464_87_A_PZ.CEL.gz	22277		42	1	alive	3395	No	No	bone marrow mononuclear cells
AML_patient_5	GSM923600	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 56	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 30	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923600/suppl/GSM923600_AHW_AML_aa_025400_100_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	56	1	dead	30	No	No	bone marrow mononuclear cells
AML_patient_6	GSM923601	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 72	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 29	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923601/suppl/GSM923601_AHW_AML_aa_025497_24_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	72	2	dead	29	No	No	bone marrow mononuclear cells
AML_patient_7	GSM923602	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 56	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 827	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923602/suppl/GSM923602_AHW_AML_aa_025553_7_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	56	4	dead	827	No	Yes	bone marrow mononuclear cells
AML_patient_8	GSM923603	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 746	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923603/suppl/GSM923603_AHW_AML_aa_030279_76_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	4	alive	746	No	No	bone marrow mononuclear cells
AML_patient_9	GSM923604	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 232	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923604/suppl/GSM923604_AHW_AML_aa_030839_1_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	1	dead	232	No	Yes	bone marrow mononuclear cells
AML_patient_10	GSM923605	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 74	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 128	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923605/suppl/GSM923605_AHW_AML_aa_030980_68_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	74	1	dead	128	No	No	bone marrow mononuclear cells
AML_patient_11	GSM923606	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1953	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923606/suppl/GSM923606_AHW_AML_aa_032604_27_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	1	alive	1953	No	No	bone marrow mononuclear cells
AML_patient_12	GSM923607	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 70	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 84	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923607/suppl/GSM923607_AHW_AML_aa_034088_65_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	70	2	dead	84	No	NA	bone marrow mononuclear cells
AML_patient_13	GSM923608	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 43	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923608/suppl/GSM923608_AHW_AML_aa_035099_35_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	2	dead	43	No	Yes	bone marrow mononuclear cells
AML_patient_14	GSM923609	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 72	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 493	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923609/suppl/GSM923609_AHW_AML_aa_035143_38_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	72	2	dead	493	No	No	bone marrow mononuclear cells
AML_patient_15	GSM923610	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 70	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 1	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923610/suppl/GSM923610_AHW_AML_aa_035147_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	70	5	dead	1	No	Yes	bone marrow mononuclear cells
AML_patient_16	GSM923611	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 75	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 317	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923611/suppl/GSM923611_AHW_AML_aa_035366_53_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	75	2	dead	317	No	No	bone marrow mononuclear cells
AML_patient_17	GSM923612	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 50	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 83	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923612/suppl/GSM923612_AHW_AML_com_025245_104_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	50	2	dead	83	No	No	bone marrow mononuclear cells
AML_patient_18	GSM923613	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 25	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923613/suppl/GSM923613_AHW_AML_com_032402_31_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	1	dead	25	No	No	bone marrow mononuclear cells
AML_patient_19	GSM923614	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 50	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 173	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923614/suppl/GSM923614_AHW_AML_com_033576_86_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	50	0	dead	173	No	No	bone marrow mononuclear cells
AML_patient_20	GSM923615	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 352	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923615/suppl/GSM923615_AHW_AML_com_035241_46_A_PZ.CEL.gz	22277		68	6	dead	352	No	No	bone marrow mononuclear cells
AML_patient_21	GSM923616	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 294	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923616/suppl/GSM923616_AHW_AML_com_035440_55_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	64	4	dead	294	No	No	bone marrow mononuclear cells
AML_patient_22	GSM923617	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 58	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 420	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923617/suppl/GSM923617_AHW_AML_del9_030758_41_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	58	2	dead	420	No	No	bone marrow mononuclear cells
AML_patient_23	GSM923618	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 37	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 3379	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923618/suppl/GSM923618_AHW_AML_M2_030243_45_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	37	2	alive	3379	Yes	No	bone marrow mononuclear cells
AML_patient_24	GSM923619	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 61	runx1-runx1t1_fusion: Yes	runx1_mutation: Yes	overall survival (days): 595	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923619/suppl/GSM923619_AHW_AML_M2_031913_98_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	61	2	dead	595	Yes	Yes	bone marrow mononuclear cells
AML_patient_25	GSM923620	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3v	age: 42	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 892	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923620/suppl/GSM923620_AHW_AML_M3v_020345_4_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	42	3v	alive	892	No	NA	bone marrow mononuclear cells
AML_patient_26	GSM923621	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3v	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 2706	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923621/suppl/GSM923621_AHW_AML_M3v_024443_69_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	3v	alive	2706	No	NA	bone marrow mononuclear cells
AML_patient_27	GSM923622	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 78	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 2	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923622/suppl/GSM923622_AHW_AML_M3v_031869_49_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	78	NA	dead	2	No	NA	bone marrow mononuclear cells
AML_patient_28	GSM923623	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 78	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3242	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923623/suppl/GSM923623_AHW_AML_M4eo_024932_102_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	78	4	alive	3242	No	No	bone marrow mononuclear cells
AML_patient_29	GSM923624	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 44	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3141	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923624/suppl/GSM923624_AHW_AML_M4eo_025649_94_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	44	4	alive	3141	No	No	bone marrow mononuclear cells
AML_patient_30	GSM923625	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 413	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923625/suppl/GSM923625_AHW_AML_M4eo_030799_12_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	4	dead	413	No	No	bone marrow mononuclear cells
AML_patient_31	GSM923626	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3117	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923626/suppl/GSM923626_AHW_AML_M4eo_035874_76_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	4	alive	3117	No	No	bone marrow mononuclear cells
AML_patient_32	GSM923627	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 35	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 33	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923627/suppl/GSM923627_AHW_AML_MLL_033938_33_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	35	1	dead	33	No	No	bone marrow mononuclear cells
AML_patient_33	GSM923628	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 44	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 403	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923628/suppl/GSM923628_AHW_AML_mo7_035881_77_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	44	2	dead	403	No	No	bone marrow mononuclear cells
AML_patient_34	GSM923629	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 425	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923629/suppl/GSM923629_AHW_AML_nk_034775_26_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	64	4	dead	425	No	Yes	bone marrow mononuclear cells
AML_patient_35	GSM923630	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 434	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923630/suppl/GSM923630_AHW_AML_nk_035077_32_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	2	dead	434	No	Yes	bone marrow mononuclear cells
AML_patient_36	GSM923631	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 48	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 66	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923631/suppl/GSM923631_AHW_AML_nk_035098_34_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	48	5	dead	66	No	No	bone marrow mononuclear cells
AML_patient_37	GSM923632	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 493	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923632/suppl/GSM923632_AHW_AML_nk_035189_41_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	4	dead	493	No	No	bone marrow mononuclear cells
AML_patient_38	GSM923633	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 52	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 658	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923633/suppl/GSM923633_AHW_AML_nk_035678_66_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	52	2	dead	658	No	No	bone marrow mononuclear cells
AML_patient_39	GSM923634	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 68	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923634/suppl/GSM923634_AHW_MDS_del5_033287_66_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	2	alive	68	No	NA	bone marrow mononuclear cells
AML_patient_40	GSM923635	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 393	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923635/suppl/GSM923635_AHW_MDS_RAEO_032831_16_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	NA	alive	393	No	NA	bone marrow mononuclear cells
AML_patient_41	GSM923636	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 519	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923636/suppl/GSM923636_AHW_MDS_RAEO_033604_107_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	4	dead	519	No	No	bone marrow mononuclear cells
AML_patient_42	GSM923637	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 61	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 62	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923637/suppl/GSM923637_AHW_MDS_RAEO_034971_28_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	61	NA	dead	62	No	NA	bone marrow mononuclear cells
AML_patient_43	GSM923638	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 47	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 657	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923638/suppl/GSM923638_ALK_AML_13_013997_10_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	47	6	dead	657	No	No	bone marrow mononuclear cells
AML_patient_44	GSM923639	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 44	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923639/suppl/GSM923639_ALK_AML_13_024539_31_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	1	dead	44	No	NA	bone marrow mononuclear cells
AML_patient_45	GSM923640	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 26	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2128	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923640/suppl/GSM923640_ALK_AML_321_000936_33_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	26	2	dead	2128	No	No	bone marrow mononuclear cells
AML_patient_46	GSM923641	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 155	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923641/suppl/GSM923641_ALK_AML_69_021618_40_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	5	alive	155	No	No	bone marrow mononuclear cells
AML_patient_47	GSM923642	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 49	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 792	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923642/suppl/GSM923642_ALK_AML_69_032089_16_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	49	4	alive	792	No	No	bone marrow mononuclear cells
AML_patient_48	GSM923643	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 272	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923643/suppl/GSM923643_ALK_AML_69_034402_31_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	64	4	dead	272	No	No	bone marrow mononuclear cells
AML_patient_49	GSM923644	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 39	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 25	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923644/suppl/GSM923644_ALK_AML_816_035325_29_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	39	5	dead	25	No	No	bone marrow mononuclear cells
AML_patient_50	GSM923645	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 20	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923645/suppl/GSM923645_ALK_AML_aa_003313_1_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	1	dead	20	No	No	bone marrow mononuclear cells
AML_patient_51	GSM923646	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 32	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 35	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923646/suppl/GSM923646_ALK_AML_aa_011142_44_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	32	2	dead	35	No	No	bone marrow mononuclear cells
AML_patient_52	GSM923647	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 183	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923647/suppl/GSM923647_ALK_AML_aa_014029_38_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	2	dead	183	No	Yes	bone marrow mononuclear cells
AML_patient_53	GSM923648	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 41	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 47	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923648/suppl/GSM923648_ALK_AML_aa_014334_51_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	41	4	dead	47	No	No	bone marrow mononuclear cells
AML_patient_54	GSM923649	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 22	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923649/suppl/GSM923649_ALK_AML_aa_014655_69_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	2	dead	22	No	Yes	bone marrow mononuclear cells
AML_patient_55	GSM923650	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 54	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3621	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923650/suppl/GSM923650_ALK_AML_aa_014947_73_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	54	2	alive	3621	No	No	bone marrow mononuclear cells
AML_patient_56	GSM923651	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 78	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 80	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923651/suppl/GSM923651_ALK_AML_aa_015541_67_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	78	0	dead	80	No	Yes	bone marrow mononuclear cells
AML_patient_57	GSM923652	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1437	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923652/suppl/GSM923652_ALK_AML_aa_015569_67_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	2	alive	1437	No	No	bone marrow mononuclear cells
AML_patient_58	GSM923653	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 40	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 77	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923653/suppl/GSM923653_ALK_AML_aa_020653_97_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	40	NA	dead	77	No	NA	bone marrow mononuclear cells
AML_patient_59	GSM923654	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 36	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 338	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923654/suppl/GSM923654_ALK_AML_aa_020676_98_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	36	2	dead	338	No	Yes	bone marrow mononuclear cells
AML_patient_60	GSM923655	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1075	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923655/suppl/GSM923655_ALK_AML_aa_021120_2_A_PZ.CEL.gz	22277		63	1	dead	1075	No	No	bone marrow mononuclear cells
AML_patient_61	GSM923656	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 50	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 542	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923656/suppl/GSM923656_ALK_AML_aa_021629_18_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	50	6	alive	542	No	No	bone marrow mononuclear cells
AML_patient_62	GSM923657	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 61	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2170	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923657/suppl/GSM923657_ALK_AML_aa_022406_36_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	61	4	alive	2170	No	No	bone marrow mononuclear cells
AML_patient_63	GSM923658	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 59	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 46	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923658/suppl/GSM923658_ALK_AML_aa_022718_31_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	59	1	dead	46	No	Yes	bone marrow mononuclear cells
AML_patient_64	GSM923659	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 42	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923659/suppl/GSM923659_ALK_AML_aa_024936_58_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	1	dead	42	No	Yes	bone marrow mononuclear cells
AML_patient_65	GSM923660	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 67	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 393	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923660/suppl/GSM923660_ALK_AML_aa_025941_59_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	67	4	dead	393	No	NA	bone marrow mononuclear cells
AML_patient_66	GSM923661	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1902	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923661/suppl/GSM923661_ALK_AML_aa_031161_28_A_PZ.CEL.gz	22277		65	1	dead	1902	No	No	bone marrow mononuclear cells
AML_patient_67	GSM923662	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 29	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3267	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923662/suppl/GSM923662_ALK_AML_aa_031491_57_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	29	2	alive	3267	No	No	bone marrow mononuclear cells
AML_patient_68	GSM923663	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 29	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 648	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923663/suppl/GSM923663_ALK_AML_aa_031523_59_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	29	4	dead	648	No	No	bone marrow mononuclear cells
AML_patient_69	GSM923664	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 862	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923664/suppl/GSM923664_ALK_AML_aa_031776_13_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	4	dead	862	No	No	bone marrow mononuclear cells
AML_patient_70	GSM923665	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 48	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 1444	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923665/suppl/GSM923665_ALK_AML_aa_032068_82_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	48	2	alive	1444	No	NA	bone marrow mononuclear cells
AML_patient_71	GSM923666	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 19	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923666/suppl/GSM923666_ALK_AML_aa_034468_60_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	2	dead	19	No	Yes	bone marrow mononuclear cells
AML_patient_72	GSM923667	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 76	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 24	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923667/suppl/GSM923667_ALK_AML_aa_034606_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	76	1	dead	24	No	No	bone marrow mononuclear cells
AML_patient_73	GSM923668	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 70	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 35	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923668/suppl/GSM923668_ALK_AML_aa_034707_65_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	70	1	dead	35	No	No	bone marrow mononuclear cells
AML_patient_74	GSM923669	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 72	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 152	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923669/suppl/GSM923669_ALK_AML_aa_034722_56_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	72	2	dead	152	No	No	bone marrow mononuclear cells
AML_patient_75	GSM923670	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): NA	life status: NA	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923670/suppl/GSM923670_ALK_AML_aa_035130_30_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	NA	NA	NA	No	NA	bone marrow mononuclear cells
AML_patient_76	GSM923671	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 67	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 28	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923671/suppl/GSM923671_ALK_AML_com_000017_51_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	67	2	dead	28	No	No	bone marrow mononuclear cells
AML_patient_77	GSM923672	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 58	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 619	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923672/suppl/GSM923672_ALK_AML_com_000477_29_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	58	4	alive	619	No	No	bone marrow mononuclear cells
AML_patient_78	GSM923673	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 35	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923673/suppl/GSM923673_ALK_AML_com_000904_22_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	2	dead	35	No	No	bone marrow mononuclear cells
AML_patient_79	GSM923674	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 56	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 52	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923674/suppl/GSM923674_ALK_AML_com_001600_58_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	56	5	dead	52	No	No	bone marrow mononuclear cells
AML_patient_80	GSM923675	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 73	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 30	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923675/suppl/GSM923675_ALK_AML_com_002049_50_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	73	6	dead	30	No	No	bone marrow mononuclear cells
AML_patient_81	GSM923676	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 54	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 29	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923676/suppl/GSM923676_ALK_AML_com_002829_65_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	54	2	dead	29	No	No	bone marrow mononuclear cells
AML_patient_82	GSM923677	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 76	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 342	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923677/suppl/GSM923677_ALK_AML_com_011174_62_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	76	2	dead	342	No	No	bone marrow mononuclear cells
AML_patient_83	GSM923678	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 194	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923678/suppl/GSM923678_ALK_AML_com_011388_17_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	NA	dead	194	No	NA	bone marrow mononuclear cells
AML_patient_84	GSM923679	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 77	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 35	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923679/suppl/GSM923679_ALK_AML_com_011722_22_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	77	1	dead	35	No	No	bone marrow mononuclear cells
AML_patient_85	GSM923680	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 146	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923680/suppl/GSM923680_ALK_AML_com_012454_20_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	2	dead	146	No	No	bone marrow mononuclear cells
AML_patient_86	GSM923681	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 48	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 184	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923681/suppl/GSM923681_ALK_AML_com_013051_55_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	48	6	dead	184	No	Yes	bone marrow mononuclear cells
AML_patient_87	GSM923682	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 254	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923682/suppl/GSM923682_ALK_AML_com_013404_19_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	4	dead	254	No	No	bone marrow mononuclear cells
AML_patient_88	GSM923683	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 52	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 118	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923683/suppl/GSM923683_ALK_AML_com_014435_66_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	52	6	dead	118	No	No	bone marrow mononuclear cells
AML_patient_89	GSM923684	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 75	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923684/suppl/GSM923684_ALK_AML_com_015033_82_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	2	dead	75	No	No	bone marrow mononuclear cells
AML_patient_90	GSM923685	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 82	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923685/suppl/GSM923685_ALK_AML_com_020032_48_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	1	dead	82	No	No	bone marrow mononuclear cells
AML_patient_91	GSM923686	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 46	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923686/suppl/GSM923686_ALK_AML_com_021166_7_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	1	dead	46	No	No	bone marrow mononuclear cells
AML_patient_92	GSM923687	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 36	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 521	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923687/suppl/GSM923687_ALK_AML_com_021974_28_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	36	2	dead	521	No	No	bone marrow mononuclear cells
AML_patient_93	GSM923688	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 73	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 215	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923688/suppl/GSM923688_ALK_AML_com_022133_30_A_PZ.CEL.gz	22277		73	2	dead	215	No	No	bone marrow mononuclear cells
AML_patient_94	GSM923689	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 24	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 369	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923689/suppl/GSM923689_ALK_AML_com_022329_34_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	24	1	dead	369	No	No	bone marrow mononuclear cells
AML_patient_95	GSM923690	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 62	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 348	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923690/suppl/GSM923690_ALK_AML_com_022714_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	62	2	dead	348	No	No	bone marrow mononuclear cells
AML_patient_96	GSM923691	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 521	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923691/suppl/GSM923691_ALK_AML_com_031402_62_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	4	dead	521	No	Yes	bone marrow mononuclear cells
AML_patient_97	GSM923692	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 230	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923692/suppl/GSM923692_ALK_AML_com_031590_6_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	2	dead	230	No	No	bone marrow mononuclear cells
AML_patient_98	GSM923693	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 39	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 63	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923693/suppl/GSM923693_ALK_AML_com_031854_67_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	39	2	dead	63	No	No	bone marrow mononuclear cells
AML_patient_99	GSM923694	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 263	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923694/suppl/GSM923694_ALK_AML_com_032689_61_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	6	dead	263	No	NA	bone marrow mononuclear cells
AML_patient_100	GSM923695	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 104	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923695/suppl/GSM923695_ALK_AML_com_034804_34_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	4	dead	104	No	No	bone marrow mononuclear cells
AML_patient_101	GSM923696	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 59	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 239	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923696/suppl/GSM923696_ALK_AML_com_034859_93_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	59	0	dead	239	No	No	bone marrow mononuclear cells
AML_patient_102	GSM923697	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 372	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923697/suppl/GSM923697_ALK_AML_com_034884_38_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	2	dead	372	No	No	bone marrow mononuclear cells
AML_patient_103	GSM923698	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 74	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 72	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923698/suppl/GSM923698_ALK_AML_com_035808_69_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	74	2	dead	72	No	No	bone marrow mononuclear cells
AML_patient_104	GSM923699	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 46	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 6	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923699/suppl/GSM923699_ALK_AML_com_991480_34_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	46	1	dead	6	No	No	bone marrow mononuclear cells
AML_patient_105	GSM923700	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 363	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923700/suppl/GSM923700_ALK_AML_com_991590_36_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	2	dead	363	No	No	bone marrow mononuclear cells
AML_patient_106	GSM923701	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 59	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 303	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923701/suppl/GSM923701_ALK_AML_del5_014532_5_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	59	2	dead	303	No	No	bone marrow mononuclear cells
AML_patient_107	GSM923702	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 51	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): NA	life status: NA	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923702/suppl/GSM923702_ALK_AML_del5_022791_13_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	51	NA	NA	NA	No	NA	bone marrow mononuclear cells
AML_patient_108	GSM923703	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 58	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 547	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923703/suppl/GSM923703_ALK_AML_del5_031786_49_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	58	2	dead	547	No	Yes	bone marrow mononuclear cells
AML_patient_109	GSM923704	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 568	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923704/suppl/GSM923704_ALK_AML_del5_034965_23_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	64	2	dead	568	No	No	bone marrow mononuclear cells
AML_patient_110	GSM923705	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 41	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4501	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923705/suppl/GSM923705_ALK_AML_del9_000434_2_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	41	2	alive	4501	No	No	bone marrow mononuclear cells
AML_patient_111	GSM923706	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 19	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923706/suppl/GSM923706_ALK_AML_del9_015292_41_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	NA	dead	19	No	NA	bone marrow mononuclear cells
AML_patient_112	GSM923707	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 70	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1493	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923707/suppl/GSM923707_ALK_AML_del9_022861_33_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	70	4	dead	1493	No	No	bone marrow mononuclear cells
AML_patient_113	GSM923708	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 463	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923708/suppl/GSM923708_ALK_AML_del9_024155_22_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	64	2	dead	463	No	No	bone marrow mononuclear cells
AML_patient_114	GSM923709	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 42	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3155	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923709/suppl/GSM923709_ALK_AML_del9_031422_58_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	42	1	alive	3155	No	No	bone marrow mononuclear cells
AML_patient_115	GSM923710	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 430	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923710/suppl/GSM923710_ALK_AML_FLT3_000030_28_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	1	dead	430	No	No	bone marrow mononuclear cells
AML_patient_116	GSM923711	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 34	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 422	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923711/suppl/GSM923711_ALK_AML_FLT3_000211_27_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	34	5	dead	422	No	No	bone marrow mononuclear cells
AML_patient_117	GSM923712	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 48	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 43	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923712/suppl/GSM923712_ALK_AML_FLT3_000335_34_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	48	1	dead	43	No	No	bone marrow mononuclear cells
AML_patient_118	GSM923713	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 56	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923713/suppl/GSM923713_ALK_AML_FLT3_000385_33_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	56	5	dead	2	No	No	bone marrow mononuclear cells
AML_patient_119	GSM923714	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 55	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 53	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923714/suppl/GSM923714_ALK_AML_FLT3_001260_53_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	55	4	dead	53	No	No	bone marrow mononuclear cells
AML_patient_120	GSM923715	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 52	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 257	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923715/suppl/GSM923715_ALK_AML_FLT3_001813_40_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	52	4	dead	257	No	No	bone marrow mononuclear cells
AML_patient_121	GSM923716	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 763	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923716/suppl/GSM923716_ALK_AML_FLT3_001992_38_A_PZ.CEL.gz	22277		64	0	dead	763	No	Yes	bone marrow mononuclear cells
AML_patient_122	GSM923717	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 54	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 296	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923717/suppl/GSM923717_ALK_AML_FLT3_003264_29_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	54	5	dead	296	No	No	bone marrow mononuclear cells
AML_patient_123	GSM923718	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 48	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1966	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923718/suppl/GSM923718_ALK_AML_FLT3_003266_36_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	48	5	alive	1966	No	No	bone marrow mononuclear cells
AML_patient_124	GSM923719	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 49	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 211	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923719/suppl/GSM923719_ALK_AML_FLT3_011571_43_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	49	5	alive	211	No	No	bone marrow mononuclear cells
AML_patient_125	GSM923720	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 48	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 192	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923720/suppl/GSM923720_ALK_AML_FLT3_013503_44_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	48	5	dead	192	No	No	bone marrow mononuclear cells
AML_patient_126	GSM923721	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 26	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2664	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923721/suppl/GSM923721_ALK_AML_FLT3_022215_21_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	26	1	alive	2664	No	No	bone marrow mononuclear cells
AML_patient_127	GSM923722	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 187	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923722/suppl/GSM923722_ALK_AML_FLT3_034704_53_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	5	dead	187	No	No	bone marrow mononuclear cells
AML_patient_128	GSM923723	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): NA	life status: NA	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923723/suppl/GSM923723_ALK_AML_FLT3_990989_4_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	NA	NA	NA	No	NA	bone marrow mononuclear cells
AML_patient_129	GSM923724	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 225	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923724/suppl/GSM923724_ALK_AML_FLT3_991490_5_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	64	1	dead	225	No	NA	bone marrow mononuclear cells
AML_patient_130	GSM923725	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 62	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 215	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923725/suppl/GSM923725_ALK_AML_FLT3_991514_10_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	62	4	dead	215	No	Yes	bone marrow mononuclear cells
AML_patient_131	GSM923726	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 98	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923726/suppl/GSM923726_ALK_AML_inv3_001576_38_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	4	dead	98	No	No	bone marrow mononuclear cells
AML_patient_132	GSM923727	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 7	age: 24	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 208	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923727/suppl/GSM923727_ALK_AML_inv3_010749_10_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	24	7	dead	208	No	Yes	bone marrow mononuclear cells
AML_patient_133	GSM923728	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 40	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923728/suppl/GSM923728_ALK_AML_inv3_014121_12_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	4	dead	40	No	No	bone marrow mononuclear cells
AML_patient_134	GSM923729	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 33	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1039	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923729/suppl/GSM923729_ALK_AML_inv3_014393_40_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	33	1	alive	1039	No	No	bone marrow mononuclear cells
AML_patient_135	GSM923730	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 30	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 298	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923730/suppl/GSM923730_ALK_AML_inv3_015472_13_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	30	0	dead	298	No	No	bone marrow mononuclear cells
AML_patient_136	GSM923731	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 28	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 657	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923731/suppl/GSM923731_ALK_AML_inv3_022214_30_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	28	1	alive	657	No	No	bone marrow mononuclear cells
AML_patient_137	GSM923732	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 52	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2144	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923732/suppl/GSM923732_ALK_AML_inv3_023308_31_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	52	1	dead	2144	No	No	bone marrow mononuclear cells
AML_patient_138	GSM923733	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 329	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923733/suppl/GSM923733_ALK_AML_inv3_030936_16_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	1	dead	329	No	No	bone marrow mononuclear cells
AML_patient_139	GSM923734	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 41	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 41	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923734/suppl/GSM923734_ALK_AML_inv3_032419_19_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	41	2	dead	41	No	No	bone marrow mononuclear cells
AML_patient_140	GSM923735	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 1935	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923735/suppl/GSM923735_ALK_AML_inv3_033055_56_A_PZ.CEL.gz	22277		53	4	dead	1935	No	NA	bone marrow mononuclear cells
AML_patient_141	GSM923736	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 57	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 99	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923736/suppl/GSM923736_ALK_AML_inv3_034970_3_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	57	2	dead	99	No	Yes	bone marrow mononuclear cells
AML_patient_142	GSM923737	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): NA	life status: NA	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923737/suppl/GSM923737_ALK_AML_inv3_035215_24_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	NA	NA	NA	No	NA	bone marrow mononuclear cells
AML_patient_143	GSM923738	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 61	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923738/suppl/GSM923738_ALK_AML_inv3_035496_8_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	4	alive	61	No	No	bone marrow mononuclear cells
AML_patient_144	GSM923739	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 70	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 138	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923739/suppl/GSM923739_ALK_AML_inv3_035625_66_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	70	4	dead	138	No	No	bone marrow mononuclear cells
AML_patient_145	GSM923740	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 29	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 4484	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923740/suppl/GSM923740_ALK_AML_M2_000490_15_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	29	2	alive	4484	Yes	No	bone marrow mononuclear cells
AML_patient_146	GSM923741	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 61	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 74	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923741/suppl/GSM923741_ALK_AML_M2_003172_10_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	61	4	dead	74	Yes	No	bone marrow mononuclear cells
AML_patient_147	GSM923742	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 60	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 4083	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923742/suppl/GSM923742_ALK_AML_M2_010765_14_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	2	alive	4083	Yes	No	bone marrow mononuclear cells
AML_patient_148	GSM923743	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 52	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 876	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923743/suppl/GSM923743_ALK_AML_M2_011150_n3_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	52	2	dead	876	Yes	No	bone marrow mononuclear cells
AML_patient_149	GSM923744	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 51	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 27	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923744/suppl/GSM923744_ALK_AML_M2_012622_45_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	51	2	dead	27	Yes	No	bone marrow mononuclear cells
AML_patient_150	GSM923745	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 75	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 225	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923745/suppl/GSM923745_ALK_AML_M2_013221_6_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	75	2	dead	225	Yes	No	bone marrow mononuclear cells
AML_patient_151	GSM923746	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 63	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 76	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923746/suppl/GSM923746_ALK_AML_M2_013791_12_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	1	dead	76	Yes	No	bone marrow mononuclear cells
AML_patient_152	GSM923747	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 42	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 3926	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923747/suppl/GSM923747_ALK_AML_M2_015598_14_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	42	2	alive	3926	Yes	No	bone marrow mononuclear cells
AML_patient_153	GSM923748	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 51	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 1556	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923748/suppl/GSM923748_ALK_AML_M2_021027_30_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	51	2	alive	1556	Yes	No	bone marrow mononuclear cells
AML_patient_154	GSM923749	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 32	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 744	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923749/suppl/GSM923749_ALK_AML_M2_021348_32_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	32	2	dead	744	Yes	No	bone marrow mononuclear cells
AML_patient_155	GSM923750	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 41	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 24	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923750/suppl/GSM923750_ALK_AML_M2_023495_49_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	41	2	dead	24	Yes	No	bone marrow mononuclear cells
AML_patient_156	GSM923751	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 41	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 3949	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923751/suppl/GSM923751_ALK_AML_M2_024214_48_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	41	2	alive	3949	Yes	No	bone marrow mononuclear cells
AML_patient_157	GSM923752	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 36	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 3425	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923752/suppl/GSM923752_ALK_AML_M2_030404_50_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	36	2	alive	3425	Yes	No	bone marrow mononuclear cells
AML_patient_158	GSM923753	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 42	runx1-runx1t1_fusion: Yes	runx1_mutation: Yes	overall survival (days): 3785	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923753/suppl/GSM923753_ALK_AML_M2_031008_55_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	42	2	alive	3785	Yes	Yes	bone marrow mononuclear cells
AML_patient_159	GSM923754	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 56	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 53	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923754/suppl/GSM923754_ALK_AML_M2_031717_33_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	56	2	dead	53	Yes	No	bone marrow mononuclear cells
AML_patient_160	GSM923755	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 38	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 3228	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923755/suppl/GSM923755_ALK_AML_M2_032348_21_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	38	2	alive	3228	Yes	No	bone marrow mononuclear cells
AML_patient_161	GSM923756	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 39	runx1-runx1t1_fusion: Yes	runx1_mutation: NA	overall survival (days): 566	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923756/suppl/GSM923756_ALK_AML_M2_035034_12_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	39	2	alive	566	Yes	NA	bone marrow mononuclear cells
AML_patient_162	GSM923757	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 69	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 2831	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923757/suppl/GSM923757_ALK_AML_M2_035538_44_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	2	alive	2831	Yes	No	bone marrow mononuclear cells
AML_patient_163	GSM923758	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 41	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 2717	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923758/suppl/GSM923758_ALK_AML_M2_990845_16_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	41	2	alive	2717	Yes	No	bone marrow mononuclear cells
AML_patient_164	GSM923759	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 20	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 65	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923759/suppl/GSM923759_ALK_AML_M2_990883_7_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	20	2	dead	65	Yes	No	bone marrow mononuclear cells
AML_patient_165	GSM923760	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 57	runx1-runx1t1_fusion: Yes	runx1_mutation: No	overall survival (days): 46	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923760/suppl/GSM923760_ALK_AML_M2_991625_19_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	57	2	dead	46	Yes	No	bone marrow mononuclear cells
AML_patient_166	GSM923761	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 3567	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923761/suppl/GSM923761_ALK_AML_M3_002746_2_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	3	alive	3567	No	NA	bone marrow mononuclear cells
AML_patient_167	GSM923762	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3	age: 21	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 1517	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923762/suppl/GSM923762_ALK_AML_M3_011738_5_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	21	3	dead	1517	No	NA	bone marrow mononuclear cells
AML_patient_168	GSM923763	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3	age: 54	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 3332	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923763/suppl/GSM923763_ALK_AML_M3_012256_6_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	54	3	alive	3332	No	NA	bone marrow mononuclear cells
AML_patient_169	GSM923764	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3	age: 51	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 1329	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923764/suppl/GSM923764_ALK_AML_M3_015601_86_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	51	3	alive	1329	No	NA	bone marrow mononuclear cells
AML_patient_170	GSM923765	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3	age: 51	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 1161	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923765/suppl/GSM923765_ALK_AML_M3_030150_67_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	51	3	dead	1161	No	NA	bone marrow mononuclear cells
AML_patient_171	GSM923766	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3	age: 51	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 23	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923766/suppl/GSM923766_ALK_AML_M3_032181_68_A_PZ.CEL.gz	22277		51	3	dead	23	No	NA	bone marrow mononuclear cells
AML_patient_172	GSM923767	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3	age: 40	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 4431	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923767/suppl/GSM923767_ALK_AML_M3_990110_3_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	40	3	alive	4431	No	NA	bone marrow mononuclear cells
AML_patient_173	GSM923768	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3	age: 82	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 17	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923768/suppl/GSM923768_ALK_AML_M3_990987_1_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	82	3	dead	17	No	NA	bone marrow mononuclear cells
AML_patient_174	GSM923769	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3v	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 5	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923769/suppl/GSM923769_ALK_AML_M3_991179_7_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	3v	dead	5	No	NA	bone marrow mononuclear cells
AML_patient_175	GSM923770	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3	age: 51	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 2368	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923770/suppl/GSM923770_ALK_AML_M3v_002060_4_A_PZ.CEL.gz	22277		51	3	alive	2368	No	NA	bone marrow mononuclear cells
AML_patient_176	GSM923771	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3v	age: 32	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 3580	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923771/suppl/GSM923771_ALK_AML_M3v_010042_10_A_PZ.CEL.gz	22277		32	3v	alive	3580	No	NA	bone marrow mononuclear cells
AML_patient_177	GSM923772	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3v	age: 36	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 1637	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923772/suppl/GSM923772_ALK_AML_M3v_010050_n1_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	36	3v	alive	1637	No	NA	bone marrow mononuclear cells
AML_patient_178	GSM923773	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3v	age: 83	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 9	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923773/suppl/GSM923773_ALK_AML_M3v_021496_31_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	83	3v	dead	9	No	NA	bone marrow mononuclear cells
AML_patient_179	GSM923774	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 50	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923774/suppl/GSM923774_ALK_AML_M3v_021887_25_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	3	dead	50	No	NA	bone marrow mononuclear cells
AML_patient_180	GSM923775	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3v	age: 45	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 3298	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923775/suppl/GSM923775_ALK_AML_M3v_022131_61_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	45	3v	alive	3298	No	NA	bone marrow mononuclear cells
AML_patient_181	GSM923776	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3v	age: 67	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 15	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923776/suppl/GSM923776_ALK_AML_M3v_990365_9_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	67	3v	dead	15	No	NA	bone marrow mononuclear cells
AML_patient_182	GSM923777	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 3v	age: 26	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 3210	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923777/suppl/GSM923777_ALK_AML_M3v_991746_3_A_PZ.CEL.gz	22277		26	3v	alive	3210	No	NA	bone marrow mononuclear cells
AML_patient_183	GSM923778	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 52	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3265	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923778/suppl/GSM923778_ALK_AML_M4eo_000401_1_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	52	4	alive	3265	No	No	bone marrow mononuclear cells
AML_patient_184	GSM923779	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 336	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923779/suppl/GSM923779_ALK_AML_M4eo_001072_8_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	4	dead	336	No	No	bone marrow mononuclear cells
AML_patient_185	GSM923780	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 20	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1523	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923780/suppl/GSM923780_ALK_AML_M4eo_001976_10_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	20	4	alive	1523	No	No	bone marrow mononuclear cells
AML_patient_186	GSM923781	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 37	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4179	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923781/suppl/GSM923781_ALK_AML_M4eo_002369_11_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	37	4	alive	4179	No	No	bone marrow mononuclear cells
AML_patient_187	GSM923782	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 33	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4166	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923782/suppl/GSM923782_ALK_AML_M4eo_002381_2_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	33	4	alive	4166	No	No	bone marrow mononuclear cells
AML_patient_188	GSM923783	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 41	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 764	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923783/suppl/GSM923783_ALK_AML_M4eo_003265_3_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	41	4	dead	764	No	No	bone marrow mononuclear cells
AML_patient_189	GSM923784	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 62	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1367	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923784/suppl/GSM923784_ALK_AML_M4eo_003282_5_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	62	4	dead	1367	No	No	bone marrow mononuclear cells
AML_patient_190	GSM923785	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 39	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1491	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923785/suppl/GSM923785_ALK_AML_M4eo_010065_22_A_PZ.CEL.gz	22277		39	4	dead	1491	No	No	bone marrow mononuclear cells
AML_patient_191	GSM923786	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 39	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3711	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923786/suppl/GSM923786_ALK_AML_M4eo_011063_13_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	39	4	alive	3711	No	No	bone marrow mononuclear cells
AML_patient_192	GSM923787	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3549	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923787/suppl/GSM923787_ALK_AML_M4eo_011121_6_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	53	4	alive	3549	No	No	bone marrow mononuclear cells
AML_patient_193	GSM923788	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 46	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923788/suppl/GSM923788_ALK_AML_M4eo_011828_n4_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	46	4	dead	4	No	No	bone marrow mononuclear cells
AML_patient_194	GSM923789	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 28	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3936	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923789/suppl/GSM923789_ALK_AML_M4eo_013204_27_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	28	4	alive	3936	No	No	bone marrow mononuclear cells
AML_patient_195	GSM923790	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 42	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3724	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923790/suppl/GSM923790_ALK_AML_M4eo_014176_52_A_PZ.CEL.gz	22277		42	4	alive	3724	No	No	bone marrow mononuclear cells
AML_patient_196	GSM923791	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 29	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1531	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923791/suppl/GSM923791_ALK_AML_M4eo_014248_49_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	29	4	alive	1531	No	No	bone marrow mononuclear cells
AML_patient_197	GSM923792	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 36	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3826	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923792/suppl/GSM923792_ALK_AML_M4eo_014708_54_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	36	4	alive	3826	No	No	bone marrow mononuclear cells
AML_patient_198	GSM923793	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 14	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923793/suppl/GSM923793_ALK_AML_M4eo_021235_13_A_PZ.CEL.gz	22277		69	4	dead	14	No	No	bone marrow mononuclear cells
AML_patient_199	GSM923794	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 49	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3649	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923794/suppl/GSM923794_ALK_AML_M4eo_021949_56_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	49	4	alive	3649	No	No	bone marrow mononuclear cells
AML_patient_200	GSM923795	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 35	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1302	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923795/suppl/GSM923795_ALK_AML_M4eo_022305_23_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	35	4	alive	1302	No	No	bone marrow mononuclear cells
AML_patient_201	GSM923796	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 55	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 33	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923796/suppl/GSM923796_ALK_AML_M4eo_023536_50_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	55	1	dead	33	No	No	bone marrow mononuclear cells
AML_patient_202	GSM923797	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 37	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4348	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923797/suppl/GSM923797_ALK_AML_M4eo_024080_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	37	4	alive	4348	No	No	bone marrow mononuclear cells
AML_patient_203	GSM923798	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 1422	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923798/suppl/GSM923798_ALK_AML_M4eo_030280_21_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	4	dead	1422	No	NA	bone marrow mononuclear cells
AML_patient_204	GSM923799	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 20	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2862	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923799/suppl/GSM923799_ALK_AML_M4eo_031061_42_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	20	4	alive	2862	No	No	bone marrow mononuclear cells
AML_patient_205	GSM923800	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 40	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3136	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923800/suppl/GSM923800_ALK_AML_M4eo_034705_67_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	40	4	alive	3136	No	No	bone marrow mononuclear cells
AML_patient_206	GSM923801	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 57	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 516	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923801/suppl/GSM923801_ALK_AML_M4eo_036052_25_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	57	4	dead	516	No	No	bone marrow mononuclear cells
AML_patient_207	GSM923802	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 18	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1903	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923802/suppl/GSM923802_ALK_AML_M4eo_036060_45_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	18	4	alive	1903	No	No	bone marrow mononuclear cells
AML_patient_208	GSM923803	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 22	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3093	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923803/suppl/GSM923803_ALK_AML_M4eo_036378_36_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	22	4	alive	3093	No	No	bone marrow mononuclear cells
AML_patient_209	GSM923804	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 34	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3098	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923804/suppl/GSM923804_ALK_AML_M4eo_036383_37_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	34	4	alive	3098	No	No	bone marrow mononuclear cells
AML_patient_210	GSM923805	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 57	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 43	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923805/suppl/GSM923805_ALK_AML_M4eo_990959_n8_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	57	4	dead	43	No	No	bone marrow mononuclear cells
AML_patient_211	GSM923806	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 39	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 65	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923806/suppl/GSM923806_ALK_AML_M4eo_991384_9_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	39	2	dead	65	No	No	bone marrow mononuclear cells
AML_patient_212	GSM923807	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3564	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923807/suppl/GSM923807_ALK_AML_M4eo_991648_17_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	4	alive	3564	No	No	bone marrow mononuclear cells
AML_patient_213	GSM923808	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 55	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 5	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923808/suppl/GSM923808_ALK_AML_MLL_001333_10_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	55	5	dead	5	No	No	bone marrow mononuclear cells
AML_patient_214	GSM923809	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 54	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 650	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923809/suppl/GSM923809_ALK_AML_MLL_001515_34_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	54	5	dead	650	No	No	bone marrow mononuclear cells
AML_patient_215	GSM923810	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 30	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 358	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923810/suppl/GSM923810_ALK_AML_MLL_001573_7_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	30	4	dead	358	No	No	bone marrow mononuclear cells
AML_patient_216	GSM923811	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 57	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923811/suppl/GSM923811_ALK_AML_MLL_002923_20_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	57	5	dead	4	No	No	bone marrow mononuclear cells
AML_patient_217	GSM923812	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 35	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 345	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923812/suppl/GSM923812_ALK_AML_MLL_010175_9_A_PZ.CEL.gz	22277		35	1	dead	345	No	No	bone marrow mononuclear cells
AML_patient_218	GSM923813	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 47	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923813/suppl/GSM923813_ALK_AML_MLL_010889_16_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	47	5	dead	2	No	No	bone marrow mononuclear cells
AML_patient_219	GSM923814	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 41	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 50	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923814/suppl/GSM923814_ALK_AML_MLL_011824_24_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	41	5	dead	50	No	No	bone marrow mononuclear cells
AML_patient_220	GSM923815	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 48	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923815/suppl/GSM923815_ALK_AML_MLL_012829_3_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	48	5	dead	4	No	No	bone marrow mononuclear cells
AML_patient_221	GSM923816	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 269	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923816/suppl/GSM923816_ALK_AML_MLL_013022_8_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	53	5	dead	269	No	No	bone marrow mononuclear cells
AML_patient_222	GSM923817	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 25	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 276	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923817/suppl/GSM923817_ALK_AML_MLL_015135_21_A_PZ.CEL.gz	22277		25	NA	dead	276	No	NA	bone marrow mononuclear cells
AML_patient_223	GSM923818	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 57	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 76	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923818/suppl/GSM923818_ALK_AML_MLL_015392_27_A_PZ.CEL.gz	22277		57	4	dead	76	No	No	bone marrow mononuclear cells
AML_patient_224	GSM923819	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 45	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3625	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923819/suppl/GSM923819_ALK_AML_MLL_015425_81_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	45	4	alive	3625	No	No	bone marrow mononuclear cells
AML_patient_225	GSM923820	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 6	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923820/suppl/GSM923820_ALK_AML_MLL_015619_25_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	5	dead	6	No	No	bone marrow mononuclear cells
AML_patient_226	GSM923821	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 33	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2298	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923821/suppl/GSM923821_ALK_AML_MLL_020258_2_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	33	5	dead	2298	No	No	bone marrow mononuclear cells
AML_patient_227	GSM923822	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 38	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 99	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923822/suppl/GSM923822_ALK_AML_MLL_020259_92_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	38	4	alive	99	No	No	bone marrow mononuclear cells
AML_patient_228	GSM923823	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 8	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923823/suppl/GSM923823_ALK_AML_MLL_021086_78_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	5	dead	8	No	No	bone marrow mononuclear cells
AML_patient_229	GSM923824	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 418	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923824/suppl/GSM923824_ALK_AML_MLL_024330_36_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	53	5	dead	418	No	No	bone marrow mononuclear cells
AML_patient_230	GSM923825	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 47	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 22	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923825/suppl/GSM923825_ALK_AML_MLL_024885_61_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	47	0	dead	22	No	No	bone marrow mononuclear cells
AML_patient_231	GSM923826	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 40	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2990	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923826/suppl/GSM923826_ALK_AML_MLL_025817_63_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	40	5	alive	2990	No	No	bone marrow mononuclear cells
AML_patient_232	GSM923827	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 26	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3648	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923827/suppl/GSM923827_ALK_AML_MLL_030594_47_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	26	5	alive	3648	No	No	bone marrow mononuclear cells
AML_patient_233	GSM923828	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 70	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 309	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923828/suppl/GSM923828_ALK_AML_MLL_030674_6_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	70	NA	dead	309	No	NA	bone marrow mononuclear cells
AML_patient_234	GSM923829	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 21	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3252	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923829/suppl/GSM923829_ALK_AML_MLL_031674_11_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	21	1	alive	3252	No	No	bone marrow mononuclear cells
AML_patient_235	GSM923830	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 30	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2023	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923830/suppl/GSM923830_ALK_AML_MLL_033897_32_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	30	5	alive	2023	No	No	bone marrow mononuclear cells
AML_patient_236	GSM923831	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 287	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923831/suppl/GSM923831_ALK_AML_MLL_034806_64_A_PZ.CEL.gz	22277		68	5	dead	287	No	NA	bone marrow mononuclear cells
AML_patient_237	GSM923832	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 307	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923832/suppl/GSM923832_ALK_AML_MLL_991080_6_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	53	5	dead	307	No	No	bone marrow mononuclear cells
AML_patient_238	GSM923833	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 58	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 61	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923833/suppl/GSM923833_ALK_AML_MLL_991445_2_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	58	5	dead	61	No	No	bone marrow mononuclear cells
AML_patient_239	GSM923834	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 72	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923834/suppl/GSM923834_ALK_AML_MLLd_001839_37_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	72	1	dead	4	No	No	bone marrow mononuclear cells
AML_patient_240	GSM923835	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 42	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 918	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923835/suppl/GSM923835_ALK_AML_MLLd_003253_32_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	42	4	dead	918	No	No	bone marrow mononuclear cells
AML_patient_241	GSM923836	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 76	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1104	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923836/suppl/GSM923836_ALK_AML_MLLd_011213_45_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	76	6	dead	1104	No	No	bone marrow mononuclear cells
AML_patient_242	GSM923837	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 76	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 2423	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923837/suppl/GSM923837_ALK_AML_MLLd_011408_48_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	76	2	dead	2423	No	Yes	bone marrow mononuclear cells
AML_patient_243	GSM923838	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 74	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 244	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923838/suppl/GSM923838_ALK_AML_MLLd_011934_56_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	74	1	dead	244	No	Yes	bone marrow mononuclear cells
AML_patient_244	GSM923839	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 54	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 77	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923839/suppl/GSM923839_ALK_AML_MLLd_012506_54_A_PZ.CEL.gz	22277		54	1	dead	77	No	Yes	bone marrow mononuclear cells
AML_patient_245	GSM923840	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 19	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923840/suppl/GSM923840_ALK_AML_MLLd_015204_14_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	1	dead	19	No	No	bone marrow mononuclear cells
AML_patient_246	GSM923841	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 55	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1549	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923841/suppl/GSM923841_ALK_AML_MLLd_020631_49_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	55	6	alive	1549	No	No	bone marrow mononuclear cells
AML_patient_247	GSM923842	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 59	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 150	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923842/suppl/GSM923842_ALK_AML_mo7_001305_27_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	59	4	dead	150	No	Yes	bone marrow mononuclear cells
AML_patient_248	GSM923843	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 33	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2432	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923843/suppl/GSM923843_ALK_AML_mo7_011337_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	33	2	dead	2432	No	No	bone marrow mononuclear cells
AML_patient_249	GSM923844	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 170	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923844/suppl/GSM923844_ALK_AML_mo7_012223_2_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	2	dead	170	No	Yes	bone marrow mononuclear cells
AML_patient_250	GSM923845	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 30	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 88	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923845/suppl/GSM923845_ALK_AML_mo7_031165_32_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	30	2	dead	88	No	No	bone marrow mononuclear cells
AML_patient_251	GSM923846	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 770	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923846/suppl/GSM923846_ALK_AML_mo7_034372_71_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	64	2	dead	770	No	No	bone marrow mononuclear cells
AML_patient_252	GSM923847	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 9	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923847/suppl/GSM923847_ALK_AML_mo7_991816_42_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	4	dead	9	No	No	bone marrow mononuclear cells
AML_patient_253	GSM923848	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 45	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2717	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923848/suppl/GSM923848_ALK_AML_nk_000126_19_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	45	4	alive	2717	No	No	bone marrow mononuclear cells
AML_patient_254	GSM923849	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 55	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 611	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923849/suppl/GSM923849_ALK_AML_nk_000170_43_A_PZ.CEL.gz	22277		55	2	dead	611	No	No	bone marrow mononuclear cells
AML_patient_255	GSM923850	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 45	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 252	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923850/suppl/GSM923850_ALK_AML_nk_000213_37_A_PZ.CEL.gz	22277		45	2	dead	252	No	No	bone marrow mononuclear cells
AML_patient_256	GSM923851	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 62	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1426	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923851/suppl/GSM923851_ALK_AML_nk_000218_28_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	62	2	alive	1426	No	No	bone marrow mononuclear cells
AML_patient_257	GSM923852	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 28	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 429	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923852/suppl/GSM923852_ALK_AML_nk_000230_27_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	28	1	alive	429	No	No	bone marrow mononuclear cells
AML_patient_258	GSM923853	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 62	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 261	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923853/suppl/GSM923853_ALK_AML_nk_000482_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	62	0	dead	261	No	Yes	bone marrow mononuclear cells
AML_patient_259	GSM923854	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 73	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3844	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923854/suppl/GSM923854_ALK_AML_nk_000507_21_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	73	4	alive	3844	No	No	bone marrow mononuclear cells
AML_patient_260	GSM923855	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 47	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 626	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923855/suppl/GSM923855_ALK_AML_nk_000570_22_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	47	2	dead	626	No	No	bone marrow mononuclear cells
AML_patient_261	GSM923856	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 34	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3709	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923856/suppl/GSM923856_ALK_AML_nk_000647_35_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	34	6	alive	3709	No	No	bone marrow mononuclear cells
AML_patient_262	GSM923857	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 50	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 249	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923857/suppl/GSM923857_ALK_AML_nk_000692_26_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	50	2	dead	249	No	No	bone marrow mononuclear cells
AML_patient_263	GSM923858	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 38	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3696	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923858/suppl/GSM923858_ALK_AML_nk_000733_25_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	38	5	dead	3696	No	No	bone marrow mononuclear cells
AML_patient_264	GSM923859	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 34	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3619	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923859/suppl/GSM923859_ALK_AML_nk_000946_31_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	34	0	alive	3619	No	No	bone marrow mononuclear cells
AML_patient_265	GSM923860	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 46	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 108	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923860/suppl/GSM923860_ALK_AML_nk_001145_51_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	46	4	dead	108	No	No	bone marrow mononuclear cells
AML_patient_266	GSM923861	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 43	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 121	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923861/suppl/GSM923861_ALK_AML_nk_001173_11_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	43	2	dead	121	No	No	bone marrow mononuclear cells
AML_patient_267	GSM923862	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 50	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923862/suppl/GSM923862_ALK_AML_nk_001281_13_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	5	dead	50	No	No	bone marrow mononuclear cells
AML_patient_268	GSM923863	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 61	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 308	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923863/suppl/GSM923863_ALK_AML_nk_001663_42_A_PZ.CEL.gz	22277		61	4	dead	308	No	No	bone marrow mononuclear cells
AML_patient_269	GSM923864	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 73	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 261	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923864/suppl/GSM923864_ALK_AML_nk_001840_29_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	73	2	dead	261	No	Yes	bone marrow mononuclear cells
AML_patient_270	GSM923865	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 19	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4027	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923865/suppl/GSM923865_ALK_AML_nk_002039_4_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	19	2	alive	4027	No	No	bone marrow mononuclear cells
AML_patient_271	GSM923866	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 466	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923866/suppl/GSM923866_ALK_AML_nk_002210_17_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	5	dead	466	No	No	bone marrow mononuclear cells
AML_patient_272	GSM923867	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 52	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 283	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923867/suppl/GSM923867_ALK_AML_nk_002251_5_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	52	2	dead	283	No	No	bone marrow mononuclear cells
AML_patient_273	GSM923868	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 59	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4343	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923868/suppl/GSM923868_ALK_AML_nk_002453_41_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	59	4	alive	4343	No	No	bone marrow mononuclear cells
AML_patient_274	GSM923869	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 49	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 62	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923869/suppl/GSM923869_ALK_AML_nk_002490_24_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	49	4	dead	62	No	No	bone marrow mononuclear cells
AML_patient_275	GSM923870	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 72	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 292	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923870/suppl/GSM923870_ALK_AML_nk_002567_31_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	72	2	dead	292	No	Yes	bone marrow mononuclear cells
AML_patient_276	GSM923871	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 122	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923871/suppl/GSM923871_ALK_AML_nk_002616_30_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	5	dead	122	No	No	bone marrow mononuclear cells
AML_patient_277	GSM923872	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 54	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 111	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923872/suppl/GSM923872_ALK_AML_nk_002974_12_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	54	2	dead	111	No	No	bone marrow mononuclear cells
AML_patient_278	GSM923873	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 62	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 37	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923873/suppl/GSM923873_ALK_AML_nk_003071_20_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	62	2	dead	37	No	No	bone marrow mononuclear cells
AML_patient_279	GSM923874	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 43	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3004	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923874/suppl/GSM923874_ALK_AML_nk_003204_23_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	43	4	alive	3004	No	No	bone marrow mononuclear cells
AML_patient_280	GSM923875	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 40	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 209	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923875/suppl/GSM923875_ALK_AML_nk_010075_34_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	40	2	dead	209	No	Yes	bone marrow mononuclear cells
AML_patient_281	GSM923876	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 25	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4214	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923876/suppl/GSM923876_ALK_AML_nk_010139_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	25	1	alive	4214	No	No	bone marrow mononuclear cells
AML_patient_282	GSM923877	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 70	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 258	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923877/suppl/GSM923877_ALK_AML_nk_010253_32_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	70	1	dead	258	No	No	bone marrow mononuclear cells
AML_patient_283	GSM923878	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 26	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 43	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923878/suppl/GSM923878_ALK_AML_nk_010766_35_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	26	2	dead	43	No	No	bone marrow mononuclear cells
AML_patient_284	GSM923879	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 20	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 623	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923879/suppl/GSM923879_ALK_AML_nk_010858_21_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	20	1	dead	623	No	No	bone marrow mononuclear cells
AML_patient_285	GSM923880	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 48	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 32	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923880/suppl/GSM923880_ALK_AML_nk_010982_6_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	48	4	dead	32	No	Yes	bone marrow mononuclear cells
AML_patient_286	GSM923881	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 100	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923881/suppl/GSM923881_ALK_AML_nk_011046_45_A_PZ.CEL.gz	22277		69	2	dead	100	No	Yes	bone marrow mononuclear cells
AML_patient_287	GSM923882	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 46	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4597	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923882/suppl/GSM923882_ALK_AML_nk_011405_20_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	46	2	alive	4597	No	No	bone marrow mononuclear cells
AML_patient_288	GSM923883	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 49	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 595	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923883/suppl/GSM923883_ALK_AML_nk_011596_47_A_PZ.CEL.gz	22277		49	6	dead	595	No	No	bone marrow mononuclear cells
AML_patient_289	GSM923884	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 47	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 717	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923884/suppl/GSM923884_ALK_AML_nk_011761_46_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	47	6	dead	717	No	No	bone marrow mononuclear cells
AML_patient_290	GSM923885	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 237	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923885/suppl/GSM923885_ALK_AML_nk_011862_14_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	1	dead	237	No	No	bone marrow mononuclear cells
AML_patient_291	GSM923886	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 49	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4415	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923886/suppl/GSM923886_ALK_AML_nk_011888_40_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	49	2	alive	4415	No	No	bone marrow mononuclear cells
AML_patient_292	GSM923887	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 80	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 28	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923887/suppl/GSM923887_ALK_AML_nk_011911_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	80	4	dead	28	No	No	bone marrow mononuclear cells
AML_patient_293	GSM923888	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 62	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 125	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923888/suppl/GSM923888_ALK_AML_nk_012009_29_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	62	2	dead	125	No	No	bone marrow mononuclear cells
AML_patient_294	GSM923889	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 27	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 322	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923889/suppl/GSM923889_ALK_AML_nk_012100_57_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	27	4	dead	322	No	No	bone marrow mononuclear cells
AML_patient_295	GSM923890	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 52	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 60	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923890/suppl/GSM923890_ALK_AML_nk_012131_50_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	52	0	dead	60	No	Yes	bone marrow mononuclear cells
AML_patient_296	GSM923891	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 124	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923891/suppl/GSM923891_ALK_AML_nk_012482_38_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	1	dead	124	No	No	bone marrow mononuclear cells
AML_patient_297	GSM923892	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 257	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923892/suppl/GSM923892_ALK_AML_nk_012674_23_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	2	dead	257	No	No	bone marrow mononuclear cells
AML_patient_298	GSM923893	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 54	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 444	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923893/suppl/GSM923893_ALK_AML_nk_013432_5d_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	54	4	dead	444	No	No	bone marrow mononuclear cells
AML_patient_299	GSM923894	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 43	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923894/suppl/GSM923894_ALK_AML_nk_013687_42_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	6	dead	43	No	Yes	bone marrow mononuclear cells
AML_patient_300	GSM923895	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 67	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 40	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923895/suppl/GSM923895_ALK_AML_nk_013801_24_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	67	1	dead	40	No	No	bone marrow mononuclear cells
AML_patient_301	GSM923896	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 75	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 52	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923896/suppl/GSM923896_ALK_AML_nk_013941_47_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	75	1	dead	52	No	No	bone marrow mononuclear cells
AML_patient_302	GSM923897	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 67	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 163	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923897/suppl/GSM923897_ALK_AML_nk_014395_46_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	67	1	dead	163	No	No	bone marrow mononuclear cells
AML_patient_303	GSM923898	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 39	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3852	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923898/suppl/GSM923898_ALK_AML_nk_014517_15_A_PZ.CEL.gz	22277		39	5	alive	3852	No	No	bone marrow mononuclear cells
AML_patient_304	GSM923899	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 602	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923899/suppl/GSM923899_ALK_AML_nk_015333_75_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	1	dead	602	No	No	bone marrow mononuclear cells
AML_patient_305	GSM923900	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 72	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3642	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923900/suppl/GSM923900_ALK_AML_nk_015334_13_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	72	5	alive	3642	No	No	bone marrow mononuclear cells
AML_patient_306	GSM923901	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 45	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 240	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923901/suppl/GSM923901_ALK_AML_nk_015600_85_A_PZ.CEL.gz	22277		45	1	dead	240	No	No	bone marrow mononuclear cells
AML_patient_307	GSM923902	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 49	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 110	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923902/suppl/GSM923902_ALK_AML_nk_015617_37_A_PZ.CEL.gz	22277		49	1	dead	110	No	Yes	bone marrow mononuclear cells
AML_patient_308	GSM923903	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 177	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923903/suppl/GSM923903_ALK_AML_nk_020034_47_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	53	6	dead	177	No	No	bone marrow mononuclear cells
AML_patient_309	GSM923904	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 40	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 259	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923904/suppl/GSM923904_ALK_AML_nk_020154_3_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	40	5	dead	259	No	No	bone marrow mononuclear cells
AML_patient_310	GSM923905	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 47	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 417	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923905/suppl/GSM923905_ALK_AML_nk_020155_20_A_PZ.CEL.gz	22277		47	1	dead	417	No	No	bone marrow mononuclear cells
AML_patient_311	GSM923906	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 292	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923906/suppl/GSM923906_ALK_AML_nk_020809_4_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	2	alive	292	No	No	bone marrow mononuclear cells
AML_patient_312	GSM923907	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 77	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 31	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923907/suppl/GSM923907_ALK_AML_nk_020928_16_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	77	1	dead	31	No	Yes	bone marrow mononuclear cells
AML_patient_313	GSM923908	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 20	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 340	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923908/suppl/GSM923908_ALK_AML_nk_021632_14_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	20	4	dead	340	No	No	bone marrow mononuclear cells
AML_patient_314	GSM923909	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 794	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923909/suppl/GSM923909_ALK_AML_nk_021666_60_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	2	dead	794	No	No	bone marrow mononuclear cells
AML_patient_315	GSM923910	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 78	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 63	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923910/suppl/GSM923910_ALK_AML_nk_021776_6_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	78	1	dead	63	No	Yes	bone marrow mononuclear cells
AML_patient_316	GSM923911	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 75	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 97	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923911/suppl/GSM923911_ALK_AML_nk_022256_15_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	75	1	dead	97	No	No	bone marrow mononuclear cells
AML_patient_317	GSM923912	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 40	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 34	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923912/suppl/GSM923912_ALK_AML_nk_022889_37_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	40	1	dead	34	No	Yes	bone marrow mononuclear cells
AML_patient_318	GSM923913	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 873	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923913/suppl/GSM923913_ALK_AML_nk_023340_46_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	53	1	dead	873	No	No	bone marrow mononuclear cells
AML_patient_319	GSM923914	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 44	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 253	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923914/suppl/GSM923914_ALK_AML_nk_023747_51_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	44	4	dead	253	No	No	bone marrow mononuclear cells
AML_patient_320	GSM923915	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 316	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923915/suppl/GSM923915_ALK_AML_nk_023860_8_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	53	4	dead	316	No	No	bone marrow mononuclear cells
AML_patient_321	GSM923916	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 72	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 190	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923916/suppl/GSM923916_ALK_AML_nk_024913_45_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	72	1	dead	190	No	Yes	bone marrow mononuclear cells
AML_patient_322	GSM923917	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 55	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 231	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923917/suppl/GSM923917_ALK_AML_nk_030121_29_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	55	1	dead	231	No	No	bone marrow mononuclear cells
AML_patient_323	GSM923918	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 265	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923918/suppl/GSM923918_ALK_AML_nk_030246_44_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	1	dead	265	No	No	bone marrow mononuclear cells
AML_patient_324	GSM923919	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 47	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2812	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923919/suppl/GSM923919_ALK_AML_nk_030547_8_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	47	4	alive	2812	No	No	bone marrow mononuclear cells
AML_patient_325	GSM923920	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 38	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 273	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923920/suppl/GSM923920_ALK_AML_nk_030910_36_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	38	4	dead	273	No	No	bone marrow mononuclear cells
AML_patient_326	GSM923921	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 489	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923921/suppl/GSM923921_ALK_AML_nk_031007_7_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	2	dead	489	No	NA	bone marrow mononuclear cells
AML_patient_327	GSM923922	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 77	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 20	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923922/suppl/GSM923922_ALK_AML_nk_031166_5_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	77	2	dead	20	No	No	bone marrow mononuclear cells
AML_patient_328	GSM923923	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 78	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 8	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923923/suppl/GSM923923_ALK_AML_nk_031417_27_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	78	5	dead	8	No	No	bone marrow mononuclear cells
AML_patient_329	GSM923924	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 61	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 187	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923924/suppl/GSM923924_ALK_AML_nk_031544_32_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	61	2	dead	187	No	No	bone marrow mononuclear cells
AML_patient_330	GSM923925	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 57	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 3672	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923925/suppl/GSM923925_ALK_AML_nk_034369_12_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	57	2	alive	3672	No	Yes	bone marrow mononuclear cells
AML_patient_331	GSM923926	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 37	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2968	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923926/suppl/GSM923926_ALK_AML_nk_034401_14_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	37	2	alive	2968	No	No	bone marrow mononuclear cells
AML_patient_332	GSM923927	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 58	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1954	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923927/suppl/GSM923927_ALK_AML_nk_034427_15_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	58	4	alive	1954	No	No	bone marrow mononuclear cells
AML_patient_333	GSM923928	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 57	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3161	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923928/suppl/GSM923928_ALK_AML_nk_034428_16_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	57	4	alive	3161	No	No	bone marrow mononuclear cells
AML_patient_334	GSM923929	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 30	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): NA	life status: NA	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923929/suppl/GSM923929_ALK_AML_nk_034457_18_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	30	NA	NA	NA	No	NA	bone marrow mononuclear cells
AML_patient_335	GSM923930	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 75	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 15	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923930/suppl/GSM923930_ALK_AML_nk_034583_38_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	75	1	dead	15	No	Yes	bone marrow mononuclear cells
AML_patient_336	GSM923931	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 39	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3989	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923931/suppl/GSM923931_ALK_AML_nk_034607_40_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	39	2	alive	3989	No	No	bone marrow mononuclear cells
AML_patient_337	GSM923932	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 67	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 374	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923932/suppl/GSM923932_ALK_AML_nk_034699_83_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	67	4	dead	374	No	Yes	bone marrow mononuclear cells
AML_patient_338	GSM923933	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 32	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3024	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923933/suppl/GSM923933_ALK_AML_nk_034741_58_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	32	2	alive	3024	No	No	bone marrow mononuclear cells
AML_patient_339	GSM923934	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 49	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2968	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923934/suppl/GSM923934_ALK_AML_nk_034744_66_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	49	4	alive	2968	No	No	bone marrow mononuclear cells
AML_patient_340	GSM923935	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1391	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923935/suppl/GSM923935_ALK_AML_nk_034773_60_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	4	dead	1391	No	No	bone marrow mononuclear cells
AML_patient_341	GSM923936	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 83	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 119	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923936/suppl/GSM923936_ALK_AML_nk_034799_33_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	83	2	dead	119	No	No	bone marrow mononuclear cells
AML_patient_342	GSM923937	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 58	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 22	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923937/suppl/GSM923937_ALK_AML_nk_034948_56_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	58	4	dead	22	No	No	bone marrow mononuclear cells
AML_patient_343	GSM923938	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 44	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1222	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923938/suppl/GSM923938_ALK_AML_nk_034955_49_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	44	4	alive	1222	No	No	bone marrow mononuclear cells
AML_patient_344	GSM923939	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 695	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923939/suppl/GSM923939_ALK_AML_nk_034972_50_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	2	dead	695	No	No	bone marrow mononuclear cells
AML_patient_345	GSM923940	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 59	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 33	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923940/suppl/GSM923940_ALK_AML_nk_035153_52_A_PZ.CEL.gz	22277		59	1	dead	33	No	No	bone marrow mononuclear cells
AML_patient_346	GSM923941	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 149	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923941/suppl/GSM923941_ALK_AML_nk_035191_53_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	2	dead	149	No	No	bone marrow mononuclear cells
AML_patient_347	GSM923942	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 36	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 324	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923942/suppl/GSM923942_ALK_AML_nk_990644_26_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	36	4	dead	324	No	No	bone marrow mononuclear cells
AML_patient_348	GSM923943	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 305	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923943/suppl/GSM923943_ALK_AML_nk_990773_26_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	2	dead	305	No	No	bone marrow mononuclear cells
AML_patient_349	GSM923944	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 683	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923944/suppl/GSM923944_ALK_AML_nk_990843_11_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	1	dead	683	No	Yes	bone marrow mononuclear cells
AML_patient_350	GSM923945	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 54	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4502	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923945/suppl/GSM923945_ALK_AML_nk_990865_1_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	54	4	dead	4502	No	No	bone marrow mononuclear cells
AML_patient_351	GSM923946	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 37	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1008	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923946/suppl/GSM923946_ALK_AML_nk_990927_12_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	37	4	dead	1008	No	No	bone marrow mononuclear cells
AML_patient_352	GSM923947	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 55	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1221	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923947/suppl/GSM923947_ALK_AML_nk_990941_21_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	55	2	dead	1221	No	No	bone marrow mononuclear cells
AML_patient_353	GSM923948	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 75	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 42	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923948/suppl/GSM923948_ALK_AML_nk_990961_22_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	75	4	dead	42	No	No	bone marrow mononuclear cells
AML_patient_354	GSM923949	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 44	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 353	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923949/suppl/GSM923949_ALK_AML_nk_990995_2_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	44	2	dead	353	No	No	bone marrow mononuclear cells
AML_patient_355	GSM923950	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 55	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 324	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923950/suppl/GSM923950_ALK_AML_nk_991029_19_A_PZ.CEL.gz	22277		55	5	dead	324	No	NA	bone marrow mononuclear cells
AML_patient_356	GSM923951	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 194	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923951/suppl/GSM923951_ALK_AML_nk_991032_3_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	2	dead	194	No	No	bone marrow mononuclear cells
AML_patient_357	GSM923952	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1436	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923952/suppl/GSM923952_ALK_AML_nk_991046_42_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	1	alive	1436	No	No	bone marrow mononuclear cells
AML_patient_358	GSM923953	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 177	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923953/suppl/GSM923953_ALK_AML_nk_991072_34_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	1	dead	177	No	No	bone marrow mononuclear cells
AML_patient_359	GSM923954	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 68	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 562	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923954/suppl/GSM923954_ALK_AML_nk_991106_35_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	68	5	dead	562	No	No	bone marrow mononuclear cells
AML_patient_360	GSM923955	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 67	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3163	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923955/suppl/GSM923955_ALK_AML_nk_991120_7_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	67	1	dead	3163	No	No	bone marrow mononuclear cells
AML_patient_361	GSM923956	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 646	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923956/suppl/GSM923956_ALK_AML_nk_991177_24_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	2	dead	646	No	No	bone marrow mononuclear cells
AML_patient_362	GSM923957	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 235	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923957/suppl/GSM923957_ALK_AML_nk_991207_21_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	1	dead	235	No	No	bone marrow mononuclear cells
AML_patient_363	GSM923958	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 71	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4029	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923958/suppl/GSM923958_ALK_AML_nk_991211_23_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	71	4	dead	4029	No	No	bone marrow mononuclear cells
AML_patient_364	GSM923959	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 40	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4061	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923959/suppl/GSM923959_ALK_AML_nk_991217_19_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	40	5	alive	4061	No	No	bone marrow mononuclear cells
AML_patient_365	GSM923960	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 38	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4362	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923960/suppl/GSM923960_ALK_AML_nk_991266_33_A_PZ.CEL.gz	22277		38	1	alive	4362	No	No	bone marrow mononuclear cells
AML_patient_366	GSM923961	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 43	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 3169	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923961/suppl/GSM923961_ALK_AML_nk_991359_6_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	43	2	alive	3169	No	No	bone marrow mononuclear cells
AML_patient_367	GSM923962	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 57	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 149	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923962/suppl/GSM923962_ALK_AML_nk_991369_17_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	57	5	dead	149	No	No	bone marrow mononuclear cells
AML_patient_368	GSM923963	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 57	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2978	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923963/suppl/GSM923963_ALK_AML_nk_991398_17_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	57	5	dead	2978	No	No	bone marrow mononuclear cells
AML_patient_369	GSM923964	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 59	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 5023	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923964/suppl/GSM923964_ALK_AML_nk_991408_8_A_PZ.CEL.gz	22277		59	1	alive	5023	No	No	bone marrow mononuclear cells
AML_patient_370	GSM923965	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 29	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1183	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923965/suppl/GSM923965_ALK_AML_nk_991430_11_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	29	1	dead	1183	No	No	bone marrow mononuclear cells
AML_patient_371	GSM923966	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 61	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4474	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923966/suppl/GSM923966_ALK_AML_nk_991441_9_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	61	4	alive	4474	No	No	bone marrow mononuclear cells
AML_patient_372	GSM923967	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 61	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 230	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923967/suppl/GSM923967_ALK_AML_nk_991600_18_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	61	2	dead	230	No	No	bone marrow mononuclear cells
AML_patient_373	GSM923968	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 52	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923968/suppl/GSM923968_ALK_AML_nk_991605_10_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	53	4	dead	52	No	No	bone marrow mononuclear cells
AML_patient_374	GSM923969	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 56	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 970	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923969/suppl/GSM923969_ALK_AML_nk_991678_2_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	56	5	dead	970	No	No	bone marrow mononuclear cells
AML_patient_375	GSM923970	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4588	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923970/suppl/GSM923970_ALK_AML_nk_991744_25_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	53	4	alive	4588	No	No	bone marrow mononuclear cells
AML_patient_376	GSM923971	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 32	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 107	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923971/suppl/GSM923971_ALK_AML_nk_991932_1_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	32	1	dead	107	No	No	bone marrow mononuclear cells
AML_patient_377	GSM923972	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 77	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 301	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923972/suppl/GSM923972_ALK_AML_tr11_002011_36_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	77	1	dead	301	No	No	bone marrow mononuclear cells
AML_patient_378	GSM923973	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 97	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923973/suppl/GSM923973_ALK_AML_tr11_011449_37_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	64	2	dead	97	No	No	bone marrow mononuclear cells
AML_patient_379	GSM923974	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 72	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 1674	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923974/suppl/GSM923974_ALK_AML_tr11_030479_80_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	72	1	dead	1674	No	No	bone marrow mononuclear cells
AML_patient_380	GSM923975	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 35	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923975/suppl/GSM923975_ALK_AML_tr11_030960_13_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	1	dead	35	No	No	bone marrow mononuclear cells
AML_patient_381	GSM923976	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 42	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 4480	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923976/suppl/GSM923976_ALK_AML_tr11_991832_33_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	42	1	alive	4480	No	No	bone marrow mononuclear cells
AML_patient_382	GSM923977	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 57	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 621	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923977/suppl/GSM923977_ALK_AML_tr13_000921_54_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	57	5	dead	621	No	Yes	bone marrow mononuclear cells
AML_patient_383	GSM923978	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 51	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923978/suppl/GSM923978_ALK_AML_tr13_002180_18_A_PZ.CEL.gz	22277		53	0	dead	51	No	Yes	bone marrow mononuclear cells
AML_patient_384	GSM923979	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 50	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 74	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923979/suppl/GSM923979_ALK_AML_tr13_014749_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	50	2	dead	74	No	Yes	bone marrow mononuclear cells
AML_patient_385	GSM923980	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 73	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 366	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923980/suppl/GSM923980_ALK_AML_tr13_022044_77_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	73	0	dead	366	No	Yes	bone marrow mononuclear cells
AML_patient_386	GSM923981	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 809	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923981/suppl/GSM923981_ALK_AML_tr13_032483_57_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	1	dead	809	No	Yes	bone marrow mononuclear cells
AML_patient_387	GSM923982	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 54	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 62	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923982/suppl/GSM923982_ALK_AML_tr8_000757_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	54	2	dead	62	No	Yes	bone marrow mononuclear cells
AML_patient_388	GSM923983	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 73	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 2035	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923983/suppl/GSM923983_ALK_AML_tr8_003315_15_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	73	2	dead	2035	No	Yes	bone marrow mononuclear cells
AML_patient_389	GSM923984	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 25	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 507	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923984/suppl/GSM923984_ALK_AML_tr8_010445_54_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	25	5	dead	507	No	No	bone marrow mononuclear cells
AML_patient_390	GSM923985	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 42	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 813	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923985/suppl/GSM923985_ALK_AML_tr8_012781_70_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	42	5	dead	813	No	No	bone marrow mononuclear cells
AML_patient_391	GSM923986	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 47	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 289	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923986/suppl/GSM923986_ALK_AML_tr8_014366_58_A_PZ.CEL.gz	22277		47	1	dead	289	No	Yes	bone marrow mononuclear cells
AML_patient_392	GSM923987	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 41	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 299	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923987/suppl/GSM923987_ALK_AML_tr8_023159_53_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	41	1	alive	299	No	No	bone marrow mononuclear cells
AML_patient_393	GSM923988	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 73	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 28	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923988/suppl/GSM923988_ALK_AML_tr8_030613_56_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	73	0	dead	28	No	Yes	bone marrow mononuclear cells
AML_patient_394	GSM923989	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 7	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 113	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923989/suppl/GSM923989_ALK_AML_tr8_034538_59_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	64	7	dead	113	No	No	bone marrow mononuclear cells
AML_patient_395	GSM923990	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 63	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 729	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923990/suppl/GSM923990_ALK_AML_tr8_034885_39_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	63	0	dead	729	No	No	bone marrow mononuclear cells
AML_patient_396	GSM923991	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 77	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 107	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923991/suppl/GSM923991_ALK_AML_tr8_035405_7_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	77	4	dead	107	No	Yes	bone marrow mononuclear cells
AML_patient_397	GSM923992	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 60	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 22	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923992/suppl/GSM923992_ALK_AML_tr8_991267_25_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	60	4	dead	22	No	NA	bone marrow mononuclear cells
AML_patient_398	GSM923993	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 5	age: 31	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 620	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923993/suppl/GSM923993_ALK_AML_tr8_991339_33_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	31	5	dead	620	No	No	bone marrow mononuclear cells
AML_patient_399	GSM923994	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 80	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 109	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923994/suppl/GSM923994_ALK_AUL_034629_21_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	80	4	dead	109	No	Yes	bone marrow mononuclear cells
AML_patient_400	GSM923995	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 2	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923995/suppl/GSM923995_ALK_BAL_BA_021065_8_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	1	dead	2	No	No	bone marrow mononuclear cells
AML_patient_401	GSM923996	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 72	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 20	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923996/suppl/GSM923996_ALK_BAL_BA_025016_85_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	72	4	dead	20	No	No	bone marrow mononuclear cells
AML_patient_402	GSM923997	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 47	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923997/suppl/GSM923997_ALK_BAL_BA_034223_6_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	4	dead	47	No	No	bone marrow mononuclear cells
AML_patient_403	GSM923998	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 72	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 206	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923998/suppl/GSM923998_ALK_BAL_BA_035061_28_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	72	4	dead	206	No	No	bone marrow mononuclear cells
AML_patient_404	GSM923999	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 30	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 70	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM923nnn/GSM923999/suppl/GSM923999_ALK_BAL_BA_035488_18_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	30	1	dead	70	No	Yes	bone marrow mononuclear cells
AML_patient_405	GSM924000	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 61	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 676	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924000/suppl/GSM924000_ALK_BAL_BA_040482_10_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	61	2	dead	676	No	No	bone marrow mononuclear cells
AML_patient_406	GSM924001	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 122	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924001/suppl/GSM924001_ALK_BAL_BN_034067_1_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	1	dead	122	No	No	bone marrow mononuclear cells
AML_patient_407	GSM924002	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 4	age: 61	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 840	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924002/suppl/GSM924002_ALK_BAL_BN_035078_29_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	61	4	dead	840	No	No	bone marrow mononuclear cells
AML_patient_408	GSM924003	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 70	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 412	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924003/suppl/GSM924003_ALK_BAL_BN_040167_38_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	70	1	dead	412	No	Yes	bone marrow mononuclear cells
AML_patient_409	GSM924004	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 255	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924004/suppl/GSM924004_ALK_MDS_RAEC_002852_78_A_PZ.CEL.gz	22277		64	NA	dead	255	No	No	bone marrow mononuclear cells
AML_patient_410	GSM924005	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 0	age: 67	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 506	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924005/suppl/GSM924005_ALK_MDS_RAEC_011359_79_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	67	0	dead	506	No	No	bone marrow mononuclear cells
AML_patient_411	GSM924006	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 152	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924006/suppl/GSM924006_ALK_MDS_RAEC_014072_48_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	2	dead	152	No	NA	bone marrow mononuclear cells
AML_patient_412	GSM924007	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 53	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 13	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924007/suppl/GSM924007_ALK_MDS_RAEC_022687_38_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	53	NA	dead	13	No	NA	bone marrow mononuclear cells
AML_patient_413	GSM924008	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 70	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 139	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924008/suppl/GSM924008_ALK_MDS_RAEC_034886_40_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	70	2	dead	139	No	No	bone marrow mononuclear cells
AML_patient_414	GSM924009	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 66	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 323	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924009/suppl/GSM924009_ALK_MDS_RAEO_001885_44_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	66	2	dead	323	No	Yes	bone marrow mononuclear cells
AML_patient_415	GSM924010	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 31	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 303	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924010/suppl/GSM924010_ALK_MDS_RAEO_001973_45_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	31	NA	dead	303	No	No	bone marrow mononuclear cells
AML_patient_416	GSM924011	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 58	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 916	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924011/suppl/GSM924011_ALK_MDS_RAEO_002508_76_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	58	NA	dead	916	No	No	bone marrow mononuclear cells
AML_patient_417	GSM924012	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 2	age: 74	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 619	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924012/suppl/GSM924012_ALK_MDS_RAEO_023473_43_A_PZ.CEL.gz	22277		74	2	dead	619	No	NA	bone marrow mononuclear cells
AML_patient_418	GSM924013	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 1	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: Yes	overall survival (days): 42	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924013/suppl/GSM924013_ALK_MDS_RAEO_031238_53_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	1	dead	42	No	Yes	bone marrow mononuclear cells
AML_patient_419	GSM924014	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 64	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 316	life status: alive	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924014/suppl/GSM924014_ALK_MDS_RAEO_031526_60_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	64	NA	alive	316	No	NA	bone marrow mononuclear cells
AML_patient_420	GSM924015	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: 6	age: 48	runx1-runx1t1_fusion: No	runx1_mutation: No	overall survival (days): 706	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924015/suppl/GSM924015_ALK_MDS_RAEO_034350_16_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	48	6	dead	706	No	No	bone marrow mononuclear cells
AML_patient_421	GSM924016	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 69	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 242	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924016/suppl/GSM924016_ALK_MDS_RAEO_035203_14_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	69	NA	dead	242	No	NA	bone marrow mononuclear cells
AML_patient_422	GSM924017	Public on Feb 07 2013	Apr 27 2012	Sep 18 2019	RNA	1	bone marrow mononuclear cells	Homo sapiens	tissue: bone marrow mononuclear cells	fab: NA	age: 65	runx1-runx1t1_fusion: No	runx1_mutation: NA	overall survival (days): 231	life status: dead	Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML)	total RNA	Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.	biotin	Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols	9606	Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols	Samples were scanned using an Affymetrix GeneChip scanner	Normalization was performed using the Robust Multichip Average (RMA) method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.	GPL96	Tobias,,Herold	tobias.herold@med.uni-muenchen.de	Department of Internal Medicine III	University Hospital Grosshadern, Ludwig-Maximilians-University (LMU)	Marchioninistr. 15	Munich	81377	Germany	ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM924nnn/GSM924017/suppl/GSM924017_ALK_MDS_RAEO_040105_7_A_PZ.CEL.gz	22277	Reanalyzed by: GSE122505	65	NA	dead	231	No	NA	bone marrow mononuclear cells
